Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$115M |
| 2 |
Apple
AAPL
|
+$95.4M |
| 3 |
DXC Technology
DXC
|
+$91M |
| 4 |
Pfizer
PFE
|
+$66.9M |
| 5 |
Johnson & Johnson
JNJ
|
+$60.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
YHOO
Yahoo Inc
YHOO
|
+$121M |
| 2 |
MJN
Mead Johnson Nutrition Company
MJN
|
+$51.9M |
| 3 |
HP
HPQ
|
+$50.3M |
| 4 |
HOLX
Hologic
HOLX
|
+$45M |
| 5 |
Carlisle Companies
CSL
|
+$36.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.68% |
| 2 | Financials | 14.59% |
| 3 | Healthcare | 13.17% |
| 4 | Industrials | 11.08% |
| 5 | Consumer Discretionary | 9.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
OB
2276
DELISTED
Onebeacon Insurance Group Ltd
OB
| $1.7M | ﹤0.01% |
92,977
+494
| +0.5% | +$8.64K |
|
|
VWTR
2277
DELISTED
Vidler Water Resouces, Inc. Common Stock
VWTR
| $1.69M | ﹤0.01% |
96,784
+589
| +0.6% | +$9.64K |
|
|
KEYW
2278
DELISTED
The KEYW Holding Corporation
KEYW
| $1.69M | ﹤0.01% |
180,963
+28,883
| +19% | +$262K |
|
|
NEX
2279
DELISTED
NexTier Oilfield Solutions Inc.
NEX
| $1.68M | ﹤0.01% |
105,051
+53,089
| +102% | +$782K |
|
2280
NovoCure
NVCR
$1.96B
| $1.68M | ﹤0.01% |
97,000
+18,400
| +23% | +$238K |
|
2281
Aclaris Therapeutics
ACRS
$858M
| $1.68M | ﹤0.01% |
61,765
+17,804
| +40% | +$484K |
|
|
ITCI
2282
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $1.67M | ﹤0.01% |
134,285
-3,690
| -3% | -$42.8K |
|
|
CONN
2283
DELISTED
Conn's Inc.
CONN
| $1.67M | ﹤0.01% |
87,229
+14,314
| +20% | +$232K |
|
|
BV
2284
DELISTED
Bazaarvoice, Inc.
BV
| $1.67M | ﹤0.01% |
336,596
+2,014
| +0.6% | +$9.29K |
|
|
MB
2285
DELISTED
MINDBODY, Inc. Class A Common Stock
MB
| $1.67M | ﹤0.01% |
61,200
+33,200
| +119% | +$913K |
|
2286
Editas Medicine
EDIT
$438M
| $1.66M | ﹤0.01% |
98,646
+56,496
| +134% | +$1.02M |
|
|
IMMU
2287
DELISTED
Immunomedics Inc
IMMU
| $1.66M | ﹤0.01% |
187,348
+26,400
| +16% | +$185K |
|
2288
Greif Class B
GEF.B
$4.17B
| $1.65M | ﹤0.01% |
27,374
+209
| +0.8% | +$13.3K |
|
|
SSNI
2289
DELISTED
Silver Spring Networks, Inc.
SSNI
| $1.65M | ﹤0.01% |
146,434
+1,296
| +0.9% | +$14K |
|
2290
Houlihan Lokey
HLI
$8.83B
| $1.64M | ﹤0.01% |
46,900
+26,800
| +133% | +$910K |
|
2291
Icon
ICLR
$12.8B
| $1.64M | ﹤0.01% |
16,713
+4,692
| +39% | +$415K |
|
2292
Compañía de Minas Buenaventura
BVN
$8.62B
| $1.63M | ﹤0.01% |
142,084
-23,847
| -14% | -$287K |
|
2293
PC Connection
CNXN
$2.11B
| $1.61M | ﹤0.01% |
59,671
+394
| +0.7% | +$10.9K |
|
2294
CRA International
CRAI
$1.07B
| $1.6M | ﹤0.01% |
44,059
+25,359
| +136% | +$895K |
|
2295
Entravision Communication
EVC
$1.08B
| $1.6M | ﹤0.01% |
242,561
+1,615
| +0.7% | +$9.78K |
|
2296
Cohu
COHU
$2.45B
| $1.6M | ﹤0.01% |
101,645
+532
| +0.5% | +$9.74K |
|
2297
Evolution Petroleum
EPM
$131M
| $1.6M | ﹤0.01% |
197,353
+16,936
| +9% | +$132K |
|
2298
Myers Industries
MYE
$1.28B
| $1.59M | ﹤0.01% |
88,832
+513
| +0.6% | +$8.81K |
|
|
BKMU
2299
DELISTED
Bank Mutual Corp
BKMU
| $1.59M | ﹤0.01% |
174,174
+950
| +0.5% | +$8.82K |
|
2300
Lifecore Biomedical
LFCR
$189M
| $1.59M | ﹤0.01% |
106,809
+589
| +0.6% | +$8.2K |
|
Similar funds
Charles Schwab's Q2 2017 Portfolio in Review
As of Q2 2017, Charles Schwab held 3,236 positions worth $106B, up 6.5% from $99.9B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Charles Schwab deployed $4.41B of net new capital in Q2 2017, opening 179 new positions and adding to 2,227 existing holdings. Its largest new stake was DXC Technology: 1,371,360 shares worth $91M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was HP, an estimated $50.3M trimmed.
- Charles Schwab's largest Q2 2017 buy was DXC Technology: 1,371,360 shares worth $91M.
- Charles Schwab added most to ExxonMobil in Q2 2017, an estimated $115M increase.
- Charles Schwab's biggest Q2 2017 reduction was HP, cutting an estimated $50.3M.
- Charles Schwab fully exited Yahoo Inc in Q2 2017, selling an estimated $121M.
- Charles Schwab's ten largest holdings make up 14% of its $106B portfolio in Q2 2017.
- Charles Schwab opened 179 new positions and closed 133 in Q2 2017.
- Charles Schwab's portfolio value rose 6.5% quarter-over-quarter to $106B.
Based on Charles Schwab's 13F filing for Q2 2017, filed 2 Aug 2017.